Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-12-27 Purchase | 2022-12-29 2:34 pm | TScan Therapeutics Inc. | TCRX | Silver Brian M. Chief Financial Officer | 6,000 | $1.5362 | $9,217 | 32,885 (Direct) | View |
| 2022-03-24 Purchase | 2022-03-28 4:31 pm | TScan Therapeutics Inc. | TCRX | Silver Brian M. Chief Financial Officer | 15,000 | $3.3988 | $50,982 | 26,885 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-13 Option Award | 2023-06-15 6:09 pm | N/A 2033-06-12 | TScan Therapeutics Inc. | TCRX | Silver Brian M. Chief Financial Officer | 632,500 | $0 | 632,500 (Direct) | View |
| 2022-07-25 Option Award | 2022-07-27 4:30 pm | N/A 2032-07-24 | TScan Therapeutics Inc. | TCRX | Silver Brian M. Chief Financial Officer | 220,000 | $0 | 220,000 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 4:26 pm | N/A 2032-01-17 | TScan Therapeutics Inc. | TCRX | Silver Brian M. Chief Financial Officer | 115,000 | $0 | 115,000 (Direct) | View |